InflaRx NV (IFRX)
2.14
+0.43
(+25.15%)
USD |
NASDAQ |
Nov 14, 12:33
InflaRx Gross Profit Margin (Quarterly): -5.38K% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -5.38K% |
| March 31, 2024 | -511.9% |
| Date | Value |
|---|---|
| December 31, 2023 | -12.02K% |
| September 30, 2023 | -319.6% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-12.02K%
Minimum
Dec 2023
-319.6%
Maximum
Sep 2023
-4.56K%
Average
-2.94K%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Affimed NV | -- |
| BioNTech SE | 85.63% |
| Immatics NV | -- |
| CureVac NV | -182.1% |
| ATAI Life Sciences NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.91% |
| Return on Assets | -41.76% |
| Return on Invested Capital | -47.28% |
| Profit Margin (Quarterly) | -217.8K% |
| Operating Margin (Quarterly) | -242.2K% |
| Return on Net Operating Assets | -182.0% |